Theresa Heah
Direktor/Vorstandsmitglied bei CURATIVE BIOTECHNOLOGY, INC.
Aktive Positionen von Theresa Heah
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CURATIVE BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 31.03.2024 | - |
Independent Dir/Board Member | 31.03.2024 | - | |
Royal College of Ophthalmologists | Corporate Officer/Principal | - | - |
The Royal College of Surgeons of Edinburgh | Corporate Officer/Principal | - | - |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | Direktor/Vorstandsmitglied | 21.02.2024 | - |
Vorstandsvorsitzender | 21.02.2024 | - |
Karriereverlauf von Theresa Heah
Ehemalige bekannte Positionen von Theresa Heah
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | Geschäftsführer | - | 01.06.2021 |
Technik-/Wissenschafts-/F&E-Leiter | - | 01.06.2021 | |
APPLIED GENETIC TECHNOLOGIES CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 | 31.12.2019 |
Intergalactic Therapeutics, Inc.
Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023. | Vorstandsvorsitzender | 06.01.2023 | - |
Präsident | 06.01.2023 | - | |
AERIE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Theresa Heah
King's College London | Doctorate Degree |
European School of Management & Technology GmbH | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Vereinigtes Königreich | 4 |
Deutschland | 2 |
Operativ
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 5 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CURATIVE BIOTECHNOLOGY, INC. | Distribution Services |
Private Unternehmen | 5 |
---|---|
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Beacon Therapeutics (USA), Inc.
Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | Commercial Services |
Intergalactic Therapeutics, Inc.
Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023. | Health Technology |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | Health Technology |
- Börse
- Insiders
- Theresa Heah
- Erfahrung